Cardiac Synchronization and Tricuspid Regurgitation With Leadless Pacemaker
MICRA-SYNK
Effect of Different Pacing Sites on Cardiac Synchronization and Tricuspid Regurgitation After Leadless Pacemaker Implantation
1 other identifier
observational
40
1 country
1
Brief Summary
Comparison of cardiac synchronization and tricuspid regurgitation with or without leadless pacemaker pacing in different site
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Mar 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2022
CompletedFirst Submitted
Initial submission to the registry
February 16, 2023
CompletedFirst Posted
Study publicly available on registry
April 18, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
May 31, 2023
CompletedApril 18, 2023
December 1, 2022
1.2 years
February 16, 2023
April 16, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
The evaluation of cardiac electrical synchrony
the QRS duration after pacing
1 month
The evaluation of cardiac mechanical synchrony
①Synchronization analysis between left and right ventricles: interventricular mechanical delay (IVMD) in millisecond. ②Left ventricle synchrony analysis: septal-to-posterior wall motion delay (SPWMD) in millisecond,left pre-ejection interval(LPEI) in millisecond.
1 month
Secondary Outcomes (5)
Age may affect synchronization
1 month
BMI may affect synchronization
1 month
Blood pressure may affect synchronization
1 month
The pacemaker sensing may affect synchronization
1 month
The pacemaker lead impedance may affect synchronization
1 month
Interventions
To observe the effect of pacemaker implantation at different sites on cardiac synchronization and tricuspid regurgitation
Eligibility Criteria
patients consent to LP implantation surgery
You may qualify if:
- patients consent to LP implantation surgery
You may not qualify if:
- Patients with inferior vena cava thrombus, a cancer thrombus, an abnormal inferior vena cava;
- Patients with femoral vein stenosis and tortuosity failed to accommodate the pacemaker delivery system;
- Patients with myocardial infarction;
- Patients who have been implanted with devices that affect the pacemaker delivery system, such as vena cava filters or tricuspid valve mechanical valves;
- cannot understand or are unwilling to give informed consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Yi zhou XU
Hangzhou, Zhejiang, 310006, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Yi zhou XU
First People's Hospital of Hangzhou
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Target Duration
- 1 Year
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 16, 2023
First Posted
April 18, 2023
Study Start
March 1, 2022
Primary Completion
May 1, 2023
Study Completion
May 31, 2023
Last Updated
April 18, 2023
Record last verified: 2022-12